18.31USD-0.38%Mkt Cap: 370.16M $P/E: —1d ago
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwid…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Avg
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
Indicators:|
Key Statistics
Company
Market Cap370.16M $
Enterprise Value328.74M $
Revenue (TTM)80.53M $
Gross Profit46.22M $
Net Income (TTM)-64.72M $
Revenue/Share4.000 USD
Last Price18.31 USD
Fiscal Year EndAug 2025
MR QuarterFeb 2026
Employees212
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)20.23
PEG9.88
EV/EBITDA23.55
EV/Revenue4.08
P/S4.60
P/B2.77
EPS (TTM)-3.12
EPS (Forward)0.91
52W Range
11.0973% of range21.01
52W High21.01 USD
52W Low11.09 USD
Profitability
Gross Margin58.38%
Oper. Margin23.18%
EBITDA Margin17.34%
Profit Margin-81.74%
ROE-51.86%
ROA-49.05%
Growth
Revenue Growth8.30%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF18.13M $
CapEx (TTM)3.72M $
FCF Margin21.33%
FCF Yield4.64%
Net Debt-41.33M $
Net Debt/EBITDA-2.96
Balance Sheet
Debt/Equity0.00
Current Ratio5.47
Quick Ratio5.26
Book Value/Sh6.621 USD
Cash/Share2.071 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJul 29, 2024
Pay DateAug 5, 2024
Splits
Last Split2:1
Split DateOct 2, 2007
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.25 USD
Upside (mean)-5.8%
Target Range16.00 USD – 18.50 USD
$16.00-5.8% to mean$18.50
# Analysts2
Ownership
Shares Out.20.22M
Float16.73M
Insiders17.21%
Institutions82.69%
Short Interest
Short Ratio6.4d
Short % Float9.60%
Short % Out.6.81%
Shares Short1.38M
Short (prev mo.)1.39M
Technical
SMA 5015.82 (+15.7%)
SMA 20015.84 (+15.6%)
Beta1.32
S&P 52W Chg20.05%
Avg Vol (30d)446.34K
Avg Vol (10d)944.72K
Technical Indicators
RSI (14)67.8
MACD0.7860
MACD Signal0.7553
MACD Hist.+0.0307
BB Upper19.31 USD
BB Middle17.24 USD
BB Lower15.18 USD
BB Width23.92%
ATR (14)0.5649 USD
Vol Ratio (20d)1.58x